{"title":"华药南阳分厂成为多抗甲素基地","authors":["大洪"],"dates":[{"year":1992,"month":2,"day":21}],"parts":[{"type":"paragraph","text":"华药南阳分厂成为多抗甲素基地"},{"type":"paragraph","text":"华北制药厂南阳分厂目前已成为国内规模最大的新型抗癌常规治疗药物——多抗甲素的生产基地，年产仙翁牌多抗甲素口服液3000多万支。该药属免疫增强剂，具有改善和增强肌体的应激机能，用于晚期癌症的辅助治疗，疗效明显。（大洪）"}],"comments":[],"comment_pivots":[],"description":"","page_start":1,"page_end":1}